COCRYSTAL PHARMA, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- COCRYSTAL PHARMA, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-12-31 was $0.00.
- COCRYSTAL PHARMA, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-09-30 was $0.00.
- COCRYSTAL PHARMA, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-06-30 was $2.06M.
- COCRYSTAL PHARMA, INC. stock issued during period, value, conversion of convertible securities for fiscal 2018 was $2.06M.
- COCRYSTAL PHARMA, INC. stock issued during period, value, conversion of convertible securities for fiscal 2012 was $3.16M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $2.06M 10-K · filed 2020-03-27 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | |
| 2018-06-30 | $2.06M 10-Q · filed 2019-11-12 | |
| 2012-12-31 | $3.16M 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |